Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Originally published as JCO Early Release 10.1200/JCO.2005.04.4339 on March 20 2006

Journal of Clinical Oncology, Vol 24, No 11 (April 10), 2006: pp. 1672-1678
© 2006 American Society of Clinical Oncology.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spinola, M.
Right arrow Articles by Braun, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spinola, M.
Right arrow Articles by Braun, A.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*SNP
*UniGene
Medline Plus Health Information
*Lung Cancer
Related Articles
Right arrowRelated Editorial
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Association of the PDCD5 Locus With Lung Cancer Risk and Prognosis in Smokers

Monica Spinola, Peter Meyer, Stefan Kammerer, F. Stefania Falvella, Melanie B. Boettger, Carolyn R. Hoyal, Carmen Pignatiello, Reiner Fischer, Richard B. Roth, Ugo Pastorino, Karl Haeussinger, Matthew R. Nelson, Rainer Dierkesmann, Tommaso A. Dragani, Andreas Braun

From the Department of Experimental Oncology and Laboratories, Thoracic Surgery, Istituto Nazionale Tumori, Milan, Italy; Asklepios Clinics, Pneumology Clinic, Munich-Gauting; Genefinder Technologies Ltd, Munich; Institute of Human Genetics, Molecular Oncogenetics Division, University Hospital, Tuebingen; Clinic Schillerhoehe, Pneumology Clinic, Stuttgart-Gerlingen, Germany; and Sequenom Inc, San Diego, CA.

Address reprint requests to Tommaso A. Dragani, PhD, Department of Experimental Oncology, Istituto Nazionale Tumori, Via G. Venezian 1, 20133 Milan, Italy; e-mail: tommaso.dragani{at}istitutotumori.mi.it

PURPOSE: Whole-genome scan association analysis was carried out to identify genetic variants predictive of lung cancer risk in smokers and to confirm the identified variants in an independent sample.

PATIENTS AND METHODS: A case-control study was performed using two pools consisting of DNA from 322 German smoking lung cancer patients and 273 healthy smoking controls, respectively. A replication study was carried out using 254 Italian lung adenocarcinoma (ADCA) patients and 235 healthy controls.

RESULTS: Patients with genotypes GG or CG for the rs1862214 single nucleotide polymorphism, 5' upstream of the programmed cell death 5 (PDCD5) gene, compared with those with the common genotype CC showed an increased risk of lung cancer (odds ratio, 1.6; 95% CI, 1.2 to 2.1) and a higher incidence of poor clinical stage disease (hazard ratio [HR], 1.9; 95% CI, 1.1 to 3.4; P = .023), nodal involvement (HR, 1.9; 95% CI, 1.1 to 3.6; P = .033), and short-term survivorship (HR, 1.8; 95% CI, 1.2 to 2.6, P = .003). PDCD5 mRNA expression levels were approximately 2.4-fold lower in lung ADCA as compared to normal lung tissue. Human NCI-H520 cancer cells transfected with PDCD5 cDNA showed decreased colony-forming ability.

CONCLUSION: These results suggest that the rs1862214 polymorphism in PDCD5 is predictive for lung cancer risk and prognosis, and that PDCD5 may represent a novel tumor suppressor gene influencing lung cancer.

Supported in part by grants from Associazione and Fondazione Italiana Ricerca Cancro (AIRC and FIRC) and Fondo Investimenti Ricerca de Base (FIRB) to T.A.D.

M.S., P.M., and S.K. contributed equally to this manuscript. R.D., T.A.D., and A.B. contributed equally to this manuscript.

Terms in blue are defined in the glossary, found at the end of this article and online at www.jco.org.

Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related Editorial

  • Genetic Susceptibility to Lung Cancer
    David C. Christiani
    JCO 2006 24: 1651-1652 [Full Text]


This article has been cited by other articles:


Home page
Cancer Res.Home page
I. P. Gorlov, P. Meyer, T. Liloglou, J. Myles, M. B. Boettger, A. Cassidy, L. Girard, J. D. Minna, R. Fischer, S. Duffy, et al.
Seizure 6-Like (SEZ6L) Gene and Risk for Lung Cancer
Cancer Res., September 1, 2007; 67(17): 8406 - 8411.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Wang, D. Li, H. Fan, L. Tian, Y. Zhong, Y. Zhang, L. Yuan, C. Jin, C. Yin, and D. Ma
Cellular Uptake of Exogenous Human PDCD5 Protein
J. Biol. Chem., August 25, 2006; 281(34): 24803 - 24817.
[Abstract] [Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2006 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online